Cite
INHIBITION OF ANGIOTENSIN SIGNALING REDUCES INCIDENCE OF ANTIBODY MEDIATED ALLOGRAFT REJECTION.
MLA
Shah, Sanjay K., et al. “Inhibition of Angiotensin Signaling Reduces Incidence of Antibody Mediated Allograft Rejection.” Journal of the American College of Cardiology (JACC), vol. 55, Mar. 2010, p. A19.E176. EBSCOhost, https://doi.org/10.1016/S0735-1097(10)60177-5.
APA
Shah, S. K., Verma, D. R., Snow, G., Kfoury, A. G., Bader, F., Brunisholz, K., Drakos, S. G., Hammond, E. M., Revelo, M. P., Gilbert, E., Alharethi, R., Budge, D., Everitt, M. D., Selzman, C., & Stehlik, J. (2010). Inhibition of Angiotensin Signaling Reduces Incidence of Antibody Mediated Allograft Rejection. Journal of the American College of Cardiology (JACC), 55, A19.E176. https://doi.org/10.1016/S0735-1097(10)60177-5
Chicago
Shah, Sanjay K., Divya Ratan Verma, Greg Snow, Abadallah G. Kfoury, Feras Bader, Kim Brunisholz, Stavros G. Drakos, et al. 2010. “Inhibition of Angiotensin Signaling Reduces Incidence of Antibody Mediated Allograft Rejection.” Journal of the American College of Cardiology (JACC) 55 (March): A19.E176. doi:10.1016/S0735-1097(10)60177-5.